IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q3 2017 Holdings

Filed 2017-11-14 | 16 holdings | $215.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Deciphera Therapeutics Inc(DCPHEUR)COM24344T101$77.9K4,104,14036.2%
Irhythm Technologies Inc(IRTC)COM450056106$36.5K703,74116.9%
Edge Therapeutics IncCOM279870109$25.2K2,344,86811.7%
Oxford Immunotec Global PLCORD SHSG6855A103$14.3K852,4976.6%
Wave Life Sciences LTD(WVE)SHSY95308105$14.3K658,2596.6%
Dimension Therapeutics IncCOM25433V105$12.4K2,059,2835.7%
Crispr Therapeutics AG(CRSP)NAMEN AKH17182108$9.4K527,7304.4%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$8.5K2,340,6734.0%
Sierra Oncology IncCOM82640U107$4.3K2,798,2242.0%
Sage Therapeutics Inc(SG7)COM78667J108$2.8K44,8721.3%
Obseva SACOMH5861P103$2.1K260,3011.0%
Alder Biopharmacuticals Inc(ALDR1EUR)COM014339105$2.1K171,3641.0%
Trillium Therapeutics IncCOM89620X506$2.1K404,1591.0%
Dermira Inc(DERMEUR)COM24983L104$1.7K61,1090.8%
Marinus Pharmaceuticals IncCOM56854Q101$1.5K250,0000.7%
Otonomy IncCOM68906L105$357109,8250.2%